How early is early? Effect of oxybutynin on bladder dynamics within the first year of life in patients with spina bifida.
暂无分享,去创建一个
[1] Tiebin Liu,et al. Bladder Management and Continence Outcomes in Adults with Spina Bifida: Results from the National Spina Bifida Patient Registry, 2009 to 2015 , 2018, The Journal of urology.
[2] D. Clayton,et al. Interrater Reliability in Pediatric Urodynamic Tracings: A Pilot Study , 2017, The Journal of urology.
[3] Daniel L. Lodwick,et al. Variation in Practice Patterns for the Management of Newborn Spina Bifida in the United States. , 2017, Urology.
[4] Stacy T. Tanaka,et al. Design and Methodological Considerations of the Centers for Disease Control and Prevention Urologic and Renal Protocol for the Newborn and Young Child with Spina Bifida. , 2016, The Journal of urology.
[5] C. Cooper,et al. Multidisciplinary consensus on the classification of prenatal and postnatal urinary tract dilation (UTD classification system). , 2014, Journal of pediatric urology.
[6] T. Lehnert,et al. The effects of long-term medical treatment combined with clean intermittent catheterization in children with neurogenic detrusor overactivity , 2012, International Urology and Nephrology.
[7] R. Kirby,et al. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. , 2010, Birth defects research. Part A, Clinical and molecular teratology.
[8] B. Kogan,et al. The effects of anticholinergic drugs on attention span and short‐term memory skills in children , 2008, Neurourology and urodynamics.
[9] C. Woodhouse. Myelomeningocele: neglected aspects , 2008, Pediatric Nephrology.
[10] H. Kraemer,et al. The effect of oxybutynin treatment on cognition in children with diurnal incontinence. , 2005, The Journal of urology.
[11] S. Bauer,et al. Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomentingocele. , 1999, The Journal of urology.
[12] A. Atala,et al. The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. , 1995, The Journal of urology.
[13] P. Dik,et al. Detrusor overactivity in spina bifida: How long does it need to be treated? , 2004, Neurourology and urodynamics.